{"transactions":[{"id":721412,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-07-01T17:39:50.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":20,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Bentsur purchased 12,500 shares for $250,000 in the public offering announced on June 29, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":3688424,"source":{"system":"sec-edgar","filing":"0001104659-26-079792","document":"tm2619552-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926079792/tm2619552-1_4seq1.xml","form_type":"4"}},{"id":942285,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-01-09T21:31:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":3675924,"source":{"system":"sec-edgar","filing":"0001104659-26-002500","document":"tm262288-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926002500/tm262288-3_4seq1.xml","form_type":"4"}},{"id":1005908,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2025-11-06T13:01:11.000Z","date":"2025-11-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.72,"value":28600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 676,759 shares of restricted stock."}],"balance_after":3525924,"source":{"system":"sec-edgar","filing":"0001104659-25-107423","document":"tm2530379-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925107423/tm2530379-3_4seq1.xml","form_type":"4"}},{"id":1315295,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2025-01-03T23:09:30.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 250,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 676,759 shares of restricted stock."}],"balance_after":3520924,"source":{"system":"sec-edgar","filing":"0001104659-25-000909","document":"tm251747-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925000909/tm251747-1_4seq1.xml","form_type":"4"}},{"id":1321862,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2024-12-26T13:00:08.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":4.65,"value":20925.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $4.64 to $4.67. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3270924,"source":{"system":"sec-edgar","filing":"0001104659-24-131541","document":"tm2432030-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924131541/tm2432030-1_4seq1.xml","form_type":"4"}},{"id":1350753,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":24000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350752,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.8,"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350751,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350750,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.32,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350749,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350748,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.45,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350747,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350746,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.87,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350745,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350744,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.28,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350743,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1350742,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:55:41.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.53,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224047888/ownership.xml","form_type":"4"}},{"id":1361971,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2024-11-18T13:30:19.000Z","date":"2024-11-15","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.92,"value":98400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $4.89 to $5.00. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3266424,"source":{"system":"sec-edgar","filing":"0001104659-24-119976","document":"tm2428650-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924119976/tm2428650-1_4seq1.xml","form_type":"4"}},{"id":1516170,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2024-05-15T13:16:46.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":1940,"price":6.74,"value":13075.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.65 to $6.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3246424,"source":{"system":"sec-edgar","filing":"0001104659-24-061674","document":"tm2414527-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924061674/tm2414527-1_4seq1.xml","form_type":"4"}},{"id":1519210,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2024-05-13T12:51:26.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.4,"value":12800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.31 to $6.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3244484,"source":{"system":"sec-edgar","filing":"0001104659-24-060263","document":"tm2414233-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924060263/tm2414233-3_4seq1.xml","form_type":"4"}},{"id":1564645,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T01:01:05.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2024, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":45000,"derivative":{"exercise_price":1.53,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-010868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315224010868/ownership.xml","form_type":"4"}},{"id":1569418,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2024-03-19T12:00:13.000Z","date":"2024-03-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":10.29,"value":51450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3242484,"source":{"system":"sec-edgar","filing":"0001104659-24-035902","document":"tm249189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924035902/tm249189-1_4seq1.xml","form_type":"4"}},{"id":1761228,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-10-12T20:05:40.000Z","date":"2023-10-10","kind":"purchase","planned":false,"acquired":true,"shares":640,"price":11.08,"value":7091.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.81 to $11.6243. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3237484,"source":{"system":"sec-edgar","filing":"0001104659-23-108814","document":"tm2328332-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923108814/tm2328332-1_4seq1.xml","form_type":"4"}},{"id":1762709,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-10-10T12:30:22.000Z","date":"2023-10-09","kind":"purchase","planned":false,"acquired":true,"shares":830,"price":11.19,"value":9287.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.80 to $11.5859. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3236844,"source":{"system":"sec-edgar","filing":"0001104659-23-107889","document":"tm2328102-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923107889/tm2328102-1_4.xml","form_type":"4"}},{"id":1762708,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-10-10T12:30:22.000Z","date":"2023-10-06","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":11.27,"value":2817.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.96 to $11.35. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3236014,"source":{"system":"sec-edgar","filing":"0001104659-23-107889","document":"tm2328102-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923107889/tm2328102-1_4.xml","form_type":"4"}},{"id":1763798,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-10-06T12:37:31.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":1400,"price":11.09,"value":15526.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.7875 to $11.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3235764,"source":{"system":"sec-edgar","filing":"0001104659-23-107367","document":"tm2327960-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923107367/tm2327960-1_4seq1.xml","form_type":"4"}},{"id":1763797,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-10-06T12:37:31.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":1820,"price":10.95,"value":19929.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.76 to $11.236. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3234364,"source":{"system":"sec-edgar","filing":"0001104659-23-107367","document":"tm2327960-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923107367/tm2327960-1_4seq1.xml","form_type":"4"}},{"id":1806105,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-08-16T20:05:10.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":115,"price":15.15,"value":1742.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3232544,"source":{"system":"sec-edgar","filing":"0001104659-23-092539","document":"tm2323962-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923092539/tm2323962-1_4seq1.xml","form_type":"4"}},{"id":1806104,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-08-16T20:05:10.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":235,"price":14.34,"value":3369.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.25 to $14.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3232429,"source":{"system":"sec-edgar","filing":"0001104659-23-092539","document":"tm2323962-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923092539/tm2323962-1_4seq1.xml","form_type":"4"}},{"id":1810048,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-08-11T22:07:57.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":180,"price":14.66,"value":2638.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3232194,"source":{"system":"sec-edgar","filing":"0001104659-23-090650","document":"tm2323608d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923090650/tm2323608d1_4seq1.xml","form_type":"4"}},{"id":1810047,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-08-11T22:07:57.000Z","date":"2023-08-08","kind":"purchase","planned":false,"acquired":true,"shares":120,"price":14.83,"value":1779.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3232014,"source":{"system":"sec-edgar","filing":"0001104659-23-090650","document":"tm2323608d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923090650/tm2323608d1_4seq1.xml","form_type":"4"}},{"id":1824279,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-24T20:45:52.000Z","date":"2023-07-21","kind":"purchase","planned":false,"acquired":true,"shares":225,"price":14.85,"value":3341.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.55 to $15.14. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231894,"source":{"system":"sec-edgar","filing":"0001104659-23-083472","document":"tm2321778-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923083472/tm2321778-2_4seq1.xml","form_type":"4"}},{"id":1824278,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-24T20:45:52.000Z","date":"2023-07-20","kind":"purchase","planned":false,"acquired":true,"shares":110,"price":15.06,"value":1656.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231669,"source":{"system":"sec-edgar","filing":"0001104659-23-083472","document":"tm2321778-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923083472/tm2321778-2_4seq1.xml","form_type":"4"}},{"id":1825935,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-20T10:30:06.000Z","date":"2023-07-19","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":14.33,"value":2866.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231559,"source":{"system":"sec-edgar","filing":"0001104659-23-082535","document":"tm2321693-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923082535/tm2321693-1_4seq1.xml","form_type":"4"}},{"id":1827949,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-18T12:34:39.000Z","date":"2023-07-14","kind":"purchase","planned":false,"acquired":true,"shares":150,"price":15.03,"value":2254.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231359,"source":{"system":"sec-edgar","filing":"0001104659-23-081834","document":"tm2321526-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923081834/tm2321526-1_4seq1.xml","form_type":"4"}},{"id":1827948,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-18T12:34:39.000Z","date":"2023-07-07","kind":"purchase","planned":false,"acquired":true,"shares":110,"price":16.19,"value":1780.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231209,"source":{"system":"sec-edgar","filing":"0001104659-23-081834","document":"tm2321526-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923081834/tm2321526-1_4seq1.xml","form_type":"4"}},{"id":1833053,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-07-07T12:03:41.000Z","date":"2023-07-06","kind":"purchase","planned":false,"acquired":true,"shares":320,"price":14.88,"value":4761.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.86 to $14.90. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3231099,"source":{"system":"sec-edgar","filing":"0001104659-23-078941","document":"tm2320821-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923078941/tm2320821-1_4seq1.xml","form_type":"4"}},{"id":1843568,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-06-27T12:45:24.000Z","date":"2023-06-26","kind":"purchase","planned":false,"acquired":true,"shares":750,"price":16.5,"value":12375.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3230779,"source":{"system":"sec-edgar","filing":"0001104659-23-075030","document":"tm2319737-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923075030/tm2319737-1_4seq1.xml","form_type":"4"}},{"id":1846678,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-06-22T12:42:17.000Z","date":"2023-06-21","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":17.88,"value":8940.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3230029,"source":{"system":"sec-edgar","filing":"0001104659-23-073568","document":"tm2319376-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923073568/tm2319376-1_4seq1.xml","form_type":"4"}},{"id":1862715,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-06-09T01:28:21.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":120,"price":17.53,"value":2103.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3229529,"source":{"system":"sec-edgar","filing":"0001104659-23-069566","document":"tm2318125-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923069566/tm2318125-1_4seq1.xml","form_type":"4"}},{"id":1862714,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-06-09T01:28:21.000Z","date":"2023-06-07","kind":"purchase","planned":false,"acquired":true,"shares":230,"price":17.41,"value":4004.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3229409,"source":{"system":"sec-edgar","filing":"0001104659-23-069566","document":"tm2318125-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923069566/tm2318125-1_4seq1.xml","form_type":"4"}},{"id":1872233,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-06-01T12:00:08.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":330,"price":17.28,"value":5702.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3229179,"source":{"system":"sec-edgar","filing":"0001104659-23-066844","document":"tm2317506-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923066844/tm2317506-1_4seq1.xml","form_type":"4"}},{"id":1876760,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-26T13:29:16.000Z","date":"2023-05-24","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":17.49,"value":3498.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 426,759 shares of restricted stock."}],"balance_after":3228849,"source":{"system":"sec-edgar","filing":"0001104659-23-065198","document":"tm2317124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923065198/tm2317124-1_4seq1.xml","form_type":"4"}},{"id":1887063,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-05-18T11:00:26.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":320,"price":17.025,"value":5448.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 216,759 shares of restricted stock and 210,000 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.95 to $17.15. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":3228649,"source":{"system":"sec-edgar","filing":"0001104659-23-062078","document":"tm2316170-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923062078/tm2316170-1_4seq1.xml","form_type":"4"}},{"id":1938028,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-27T12:21:56.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":230,"price":12.13,"value":2789.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 330,000 restricted stock units."}],"balance_after":3228329,"source":{"system":"sec-edgar","filing":"0001104659-23-036892","document":"tm2310605-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923036892/tm2310605-1_4seq1.xml","form_type":"4"}},{"id":1940371,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-23T12:30:28.000Z","date":"2023-03-21","kind":"purchase","planned":false,"acquired":true,"shares":480,"price":12.08,"value":5798.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $11.95 to $12.39. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 330,000 restricted stock units."}],"balance_after":3228099,"source":{"system":"sec-edgar","filing":"0001104659-23-035861","document":"tm2310299-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923035861/tm2310299-1_4seq1.xml","form_type":"4"}},{"id":1942784,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T20:05:17.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":2300,"price":6.48,"value":14904.0,"ownership":{"direct":true},"balance_after":144736,"source":{"system":"sec-edgar","filing":"0001493152-23-008362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315223008362/ownership.xml","form_type":"4"}},{"id":1950255,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-16T20:45:35.000Z","date":"2023-03-15","kind":"purchase","acquired":true,"shares":480,"price":10.91,"value":5236.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.605 to $11.10. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 330,000 restricted stock units."}],"balance_after":3227619,"source":{"system":"sec-edgar","filing":"0001104659-23-033354","document":"tm239792-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923033354/tm239792-2_4seq1.xml","form_type":"4"}},{"id":1950254,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-03-16T20:45:35.000Z","date":"2023-03-14","kind":"purchase","acquired":true,"shares":1680,"price":10.85,"value":18228.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.71 to $10.99. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 330,000 restricted stock units."}],"balance_after":3227139,"source":{"system":"sec-edgar","filing":"0001104659-23-033354","document":"tm239792-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923033354/tm239792-2_4seq1.xml","form_type":"4"}},{"id":2054872,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2023-01-13T22:04:45.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 330,000 restricted stock units."}],"balance_after":3225459,"source":{"system":"sec-edgar","filing":"0001104659-23-003864","document":"tm232835-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923003864/tm232835-2_4seq1.xml","form_type":"4"}},{"id":2101640,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-30T22:43:13.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":150,"price":7.45,"value":1117.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3015459,"source":{"system":"sec-edgar","filing":"0001104659-22-123312","document":"tm2231703-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922123312/tm2231703-1_4seq1.xml","form_type":"4"}},{"id":2102635,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-29T21:31:03.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":150,"price":7.45,"value":1117.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3015309,"source":{"system":"sec-edgar","filing":"0001104659-22-122887","document":"tm2231558-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922122887/tm2231558-1_4seq1.xml","form_type":"4"}},{"id":2102634,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-29T21:31:03.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":150,"price":7.4,"value":1110.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3015159,"source":{"system":"sec-edgar","filing":"0001104659-22-122887","document":"tm2231558-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922122887/tm2231558-1_4seq1.xml","form_type":"4"}},{"id":2102633,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-29T21:31:03.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":150,"price":7.38,"value":1107.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3015009,"source":{"system":"sec-edgar","filing":"0001104659-22-122887","document":"tm2231558-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922122887/tm2231558-1_4seq1.xml","form_type":"4"}},{"id":2108852,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-21T13:39:24.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":500,"price":7.23,"value":3615.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3014859,"source":{"system":"sec-edgar","filing":"0001104659-22-120514","document":"tm2231008-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922120514/tm2231008-1_4seq1.xml","form_type":"4"}},{"id":2108851,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-21T13:39:24.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":250,"price":7.24,"value":1810.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3014359,"source":{"system":"sec-edgar","filing":"0001104659-22-120514","document":"tm2231008-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922120514/tm2231008-1_4seq1.xml","form_type":"4"}},{"id":2114762,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-11-16T13:30:27.000Z","date":"2022-11-10","kind":"purchase","acquired":true,"shares":1000,"price":7.07,"value":7070.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3014109,"source":{"system":"sec-edgar","filing":"0001104659-22-119361","document":"tm2227229-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922119361/tm2227229-1_4seq1.xml","form_type":"4"}},{"id":2147602,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-10-03T12:16:28.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":500,"price":7.46,"value":3730.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3013109,"source":{"system":"sec-edgar","filing":"0001104659-22-104928","document":"tm2227229-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922104928/tm2227229-1_4seq1.xml","form_type":"4"}},{"id":2147601,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-10-03T12:16:28.000Z","date":"2022-09-28","kind":"purchase","acquired":true,"shares":500,"price":7.23,"value":3615.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3012609,"source":{"system":"sec-edgar","filing":"0001104659-22-104928","document":"tm2227229-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922104928/tm2227229-1_4seq1.xml","form_type":"4"}},{"id":2150605,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-09-27T12:44:17.000Z","date":"2022-09-26","kind":"purchase","acquired":true,"shares":500,"price":7.69,"value":3845.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3012109,"source":{"system":"sec-edgar","filing":"0001104659-22-103162","document":"tm2226689-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922103162/tm2226689-1_4seq1.xml","form_type":"4"}},{"id":2150604,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-09-27T12:44:17.000Z","date":"2022-09-23","kind":"purchase","acquired":true,"shares":1000,"price":7.93,"value":7930.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3011609,"source":{"system":"sec-edgar","filing":"0001104659-22-103162","document":"tm2226689-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922103162/tm2226689-1_4seq1.xml","form_type":"4"}},{"id":2165969,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-09-06T12:00:50.000Z","date":"2022-09-02","kind":"purchase","acquired":true,"shares":1200,"price":8.37,"value":10044.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3010609,"source":{"system":"sec-edgar","filing":"0001104659-22-097694","document":"tm2225158d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922097694/tm2225158d2_4seq1.xml","form_type":"4"}},{"id":2165968,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-09-06T12:00:50.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":500,"price":8.11,"value":4055.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3009409,"source":{"system":"sec-edgar","filing":"0001104659-22-097694","document":"tm2225158d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922097694/tm2225158d2_4seq1.xml","form_type":"4"}},{"id":2170892,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-08-30T11:35:34.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":1000,"price":9.07,"value":9070.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.99 to $9.31. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3008909,"source":{"system":"sec-edgar","filing":"0001104659-22-095830","document":"tm2224779-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922095830/tm2224779-1_4seq1.xml","form_type":"4"}},{"id":2170891,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-08-30T11:35:34.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":500,"price":9,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3007909,"source":{"system":"sec-edgar","filing":"0001104659-22-095830","document":"tm2224779-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922095830/tm2224779-1_4seq1.xml","form_type":"4"}},{"id":2177103,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-08-22T13:00:39.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":5000,"price":8.99,"value":44950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3007409,"source":{"system":"sec-edgar","filing":"0001104659-22-093128","document":"tm2224247-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922093128/tm2224247-1_4seq1.xml","form_type":"4"}},{"id":2177102,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-08-22T13:00:39.000Z","date":"2022-08-18","kind":"purchase","acquired":true,"shares":14426,"price":8.58,"value":123775.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.55 to $8.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":3002409,"source":{"system":"sec-edgar","filing":"0001104659-22-093128","document":"tm2224247-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922093128/tm2224247-1_4seq1.xml","form_type":"4"}},{"id":2184472,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-08-16T20:05:32.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":19669,"price":8.4,"value":165219.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.31 to $8.50. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2987983,"source":{"system":"sec-edgar","filing":"0001104659-22-091746","document":"tm2223621-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922091746/tm2223621-1_4seq1.xml","form_type":"4"}},{"id":2214187,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T20:44:17.000Z","date":"2022-06-30","kind":"sale","acquired":false,"shares":40000,"price":6.5276,"value":261104.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.57, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017."}],"balance_after":142436,"source":{"system":"sec-edgar","filing":"0001493152-22-018552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315222018552/ownership.xml","form_type":"4"}},{"id":2218789,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-30T12:30:22.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":3700,"price":11.62,"value":42994.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $11.60 to $11.70. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2968314,"source":{"system":"sec-edgar","filing":"0001104659-22-076049","document":"tm2220119-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922076049/tm2220119-1_4seq1.xml","form_type":"4"}},{"id":2218788,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-30T12:30:22.000Z","date":"2022-06-28","kind":"purchase","acquired":true,"shares":300,"price":11.82,"value":3546.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2964614,"source":{"system":"sec-edgar","filing":"0001104659-22-076049","document":"tm2220119-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922076049/tm2220119-1_4seq1.xml","form_type":"4"}},{"id":2221371,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-27T12:31:52.000Z","date":"2022-06-24","kind":"purchase","acquired":true,"shares":400,"price":12.18,"value":4872.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $12.01 to $12.34. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2964314,"source":{"system":"sec-edgar","filing":"0001104659-22-074544","document":"tm2219464-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922074544/tm2219464-1_4seq1.xml","form_type":"4"}},{"id":2221370,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-27T12:31:52.000Z","date":"2022-06-23","kind":"purchase","acquired":true,"shares":200,"price":11.4,"value":2280.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2963914,"source":{"system":"sec-edgar","filing":"0001104659-22-074544","document":"tm2219464-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922074544/tm2219464-1_4seq1.xml","form_type":"4"}},{"id":2221369,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-27T12:31:52.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":100,"price":13.1,"value":1310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2963714,"source":{"system":"sec-edgar","filing":"0001104659-22-074544","document":"tm2219464-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922074544/tm2219464-1_4seq1.xml","form_type":"4"}},{"id":2251644,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-31T12:31:27.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":500,"price":15.74,"value":7870.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2963614,"source":{"system":"sec-edgar","filing":"0001104659-22-066269","document":"tm2217208-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922066269/tm2217208-1_4seq1.xml","form_type":"4"}},{"id":2251643,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-31T12:31:27.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":500,"price":15.9,"value":7950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2963114,"source":{"system":"sec-edgar","filing":"0001104659-22-066269","document":"tm2217208-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922066269/tm2217208-1_4seq1.xml","form_type":"4"}},{"id":2260280,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-23T12:32:21.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":1000,"price":16.28,"value":16280.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2962614,"source":{"system":"sec-edgar","filing":"0001104659-22-063645","document":"tm2216562-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922063645/tm2216562-2_4seq1.xml","form_type":"4"}},{"id":2260279,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-23T12:32:21.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":200,"price":18.95,"value":3790.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2961614,"source":{"system":"sec-edgar","filing":"0001104659-22-063645","document":"tm2216562-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922063645/tm2216562-2_4seq1.xml","form_type":"4"}},{"id":2264032,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-19T14:21:00.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":1000,"price":18.49,"value":18490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.45 to $18.50. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2961414,"source":{"system":"sec-edgar","filing":"0001104659-22-062766","document":"tm2216045d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922062766/tm2216045d1_4.xml","form_type":"4"}},{"id":2264031,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-19T14:21:00.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":700,"price":20.6,"value":14420.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $20.10 to $20.82. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2960414,"source":{"system":"sec-edgar","filing":"0001104659-22-062766","document":"tm2216045d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922062766/tm2216045d1_4.xml","form_type":"4"}},{"id":2264030,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-19T14:21:00.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":110,"price":20.83,"value":2291.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2959714,"source":{"system":"sec-edgar","filing":"0001104659-22-062766","document":"tm2216045d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922062766/tm2216045d1_4.xml","form_type":"4"}},{"id":2264029,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-19T14:21:00.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":200,"price":19.77,"value":3954.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $19.75 to $19.79. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2959604,"source":{"system":"sec-edgar","filing":"0001104659-22-062766","document":"tm2216045d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922062766/tm2216045d1_4.xml","form_type":"4"}},{"id":2268483,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-17T12:30:35.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":1000,"price":19.32,"value":19320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $19.00 to $19.68. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2959404,"source":{"system":"sec-edgar","filing":"0001104659-22-061753","document":"tm2215754-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922061753/tm2215754-1_4seq1.xml","form_type":"4"}},{"id":2268482,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-17T12:30:35.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":700,"price":18.1,"value":12670.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $17.80 to $18.51. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2958404,"source":{"system":"sec-edgar","filing":"0001104659-22-061753","document":"tm2215754-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922061753/tm2215754-1_4seq1.xml","form_type":"4"}},{"id":2272272,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T12:30:14.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":10545,"price":17.26,"value":182006.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $17.01 to $17.53. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2957704,"source":{"system":"sec-edgar","filing":"0001104659-22-059888","document":"tm2215423-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922059888/tm2215423-4_4seq1.xml","form_type":"4"}},{"id":2272271,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T12:30:14.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":600,"price":16.12,"value":9672.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.90 to $16.33. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2947159,"source":{"system":"sec-edgar","filing":"0001104659-22-059888","document":"tm2215423-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922059888/tm2215423-4_4seq1.xml","form_type":"4"}},{"id":2272270,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T12:30:14.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":1100,"price":14.88,"value":16368.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.73 to $15.45. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2946559,"source":{"system":"sec-edgar","filing":"0001104659-22-059888","document":"tm2215423-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922059888/tm2215423-4_4seq1.xml","form_type":"4"}},{"id":2305007,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-04-05T20:46:00.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock and 120,000 restricted stock units."}],"balance_after":2945459,"source":{"system":"sec-edgar","filing":"0001104659-22-042813","document":"tm2211420-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922042813/tm2211420-1_4seq1.xml","form_type":"4"}},{"id":2315541,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-03-29T12:31:50.000Z","date":"2022-03-28","kind":"purchase","acquired":true,"shares":4000,"price":7.05,"value":28200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2825459,"source":{"system":"sec-edgar","filing":"0001104659-22-039119","document":"tm2210671-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922039119/tm2210671-1_4seq1.xml","form_type":"4"}},{"id":2324991,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-03-18T12:31:48.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":7000,"price":7.63,"value":53410.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2821459,"source":{"system":"sec-edgar","filing":"0001104659-22-035347","document":"tm229700-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922035347/tm229700-1_4.xml","form_type":"4"}},{"id":2347381,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T13:33:11.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2022, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":30000,"derivative":{"exercise_price":6.87,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-22-006146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315222006146/ownership.xml","form_type":"4"}},{"id":2394793,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-15T14:15:54.000Z","date":"2022-02-14","kind":"purchase","acquired":true,"shares":8000,"price":5.88,"value":47040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.50 to $6.10. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2814459,"source":{"system":"sec-edgar","filing":"0001104659-22-023547","document":"tm226759d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922023547/tm226759d1_4.xml","form_type":"4"}},{"id":2402057,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-11T14:15:43.000Z","date":"2022-02-10","kind":"purchase","acquired":true,"shares":8500,"price":6.34,"value":53890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.27 to $6.35. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2806459,"source":{"system":"sec-edgar","filing":"0001104659-22-019955","document":"tm226323d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922019955/tm226323d1_4.xml","form_type":"4"}},{"id":2408669,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-08T18:13:59.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":6000,"price":8.25,"value":49500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2797959,"source":{"system":"sec-edgar","filing":"0001104659-22-013142","document":"tm225864-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922013142/tm225864-1_4.xml","form_type":"4"}},{"id":2408668,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-08T18:13:59.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":14000,"price":3.93,"value":55020.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.60 to $4.25. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2791959,"source":{"system":"sec-edgar","filing":"0001104659-22-013142","document":"tm225864-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922013142/tm225864-1_4.xml","form_type":"4"}},{"id":2408667,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-08T18:13:59.000Z","date":"2022-02-04","kind":"purchase","acquired":true,"shares":12500,"price":3.89,"value":48625.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.83 to $3.95. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2777959,"source":{"system":"sec-edgar","filing":"0001104659-22-013142","document":"tm225864-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922013142/tm225864-1_4.xml","form_type":"4"}},{"id":2408666,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock, par value $0.00001","published_at":"2022-02-08T18:13:59.000Z","date":"2022-02-04","kind":"purchase","acquired":true,"shares":200000,"price":5,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the price of shares of common stock purchased by Mr. Bentsur in Nuvectis Pharma's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 96,759 shares of restricted stock."}],"balance_after":2765459,"source":{"system":"sec-edgar","filing":"0001104659-22-013142","document":"tm225864-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922013142/tm225864-1_4.xml","form_type":"4"}},{"id":2494069,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-26T22:19:26.000Z","date":"2021-11-24","kind":"sale","acquired":false,"shares":6464,"price":13.99,"value":90431.36,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"As previously reported, on November 22, 2021, shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the \"Company\") were issued to the reporting person in connection with the exercise of a warrant to purchase 50,000 shares of common stock of the Company for $3.66 a share on a cashless exercise basis, resulting in the Company's withholding of 12,536 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 37,464 shares of common stock of the Company. These transactions were exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3. On November 24, 2021, the reporting person sold the 37,464 shares of common stock of the Company acquired in connection with the warrant exercise."}],"balance_after":182436,"source":{"system":"sec-edgar","filing":"0001493152-21-029937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315221029937/ownership.xml","form_type":"4"}},{"id":2494068,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-26T22:19:26.000Z","date":"2021-11-24","kind":"sale","acquired":false,"shares":31000,"price":13.44,"value":416640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.9394 to $13.9389, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"As previously reported, on November 22, 2021, shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the \"Company\") were issued to the reporting person in connection with the exercise of a warrant to purchase 50,000 shares of common stock of the Company for $3.66 a share on a cashless exercise basis, resulting in the Company's withholding of 12,536 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 37,464 shares of common stock of the Company. These transactions were exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3. On November 24, 2021, the reporting person sold the 37,464 shares of common stock of the Company acquired in connection with the warrant exercise."}],"balance_after":188900,"source":{"system":"sec-edgar","filing":"0001493152-21-029937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315221029937/ownership.xml","form_type":"4"}},{"id":2494961,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":34046,"kind":"person","name":"BENTSUR RON","position":1,"cik":"0001251213","reported_name":"BENTSUR RON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2021-11-24T21:15:38.000Z","date":"2021-11-22","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.66,"exercise_date":"2017-01-13","expiration_date":"2022-01-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-029833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251213/000149315221029833/ownership.xml","form_type":"4"}}],"next_cursor":"2021-11-24T21:15:38.000000Z,2494961"}